OPERATING BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION (Tables)

12 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Schedule of reportable business segment information

Reportable business segment information for the years ended December 31, 2019 and 2018 is as follows (dollar amounts in thousands):

Year Ended December 31,	2019		2018
Net sales:
Asia	$	138,536	$	139,031
Europe	62,523		56,314
North America	138,163		144,264
Latin America and Other	22,993		25,201
Total net sales	362,215		364,810
Contribution margin (1):
Asia	65,871		67,733
Europe	19,954		17,845
North America	49,327		48,448
Latin America and Other	9,713		9,756
Total contribution margin	144,865		143,782
Selling, general and administrative (2)	128,740		138,431
Operating income	16,125		5,351
Other income (loss), net	(483)		(2,151)
Income before provision for income taxes	$	15,642	$	3,200

___________________________

(1) Contribution margin consists of net sales less cost of sales and volume incentives expense.

(2)  Service fees in China totaled $9.4 million and $11.5 million for the years ended December 31, 2019 and 2018, respectively. These service fees are included in our selling, general and administrative expenses.

Year Ended December 31,	2019		2018
Capital expenditures:
Asia	$	3,262	$	1,557
Europe	27		85
North America	2,605		3,143
Latin America and Other	21		18
Total capital expenditures	$	5,915	$	4,803
Depreciation and amortization:
Asia	$	1,544	$	799
Europe	75		107
North America	8,855		8,718
Latin America and Other	125		182
Total depreciation and amortization	$	10,599	$	9,806

As of December 31,	2019		2018
Assets:
Asia	$	65,959	$	59,983
Europe	15,187		16,414
North America	124,337		109,091
Latin America and Other	7,585		7,528
Total assets	$	213,068	$	193,016

Schedule of consolidated net sales revenue by geographical locations

From an individual country perspective, only the United States and South Korea comprise approximately 10 percent or more of consolidated net sales for the years ended December 31, 2019 and 2018 as follows (dollar amounts in thousands):

Year Ended December 31,	2019		2018
Net sales:
United States	$	128,019	$	133,677
South Korea	70,556		72,207
Other	163,640		158,926
Total net sales	$	362,215	$	364,810

Schedule of revenue generated by each of the Company's product lines

Revenue generated by each of our product lines is set forth below (dollars in thousands):

Year Ended December 31,	2019		2018
Asia:
General health	$	37,795	$	32,519
Immunity	940		3,086
Cardiovascular	44,541		49,210
Digestive	24,434		24,015
Personal care	13,753		10,286
Weight management	17,073		19,915
	138,536		139,031
Europe:
General health	$	22,469	$	20,932
Immunity	5,130		3,775
Cardiovascular	10,672		11,307
Digestive	14,456		12,478
Personal care	7,463		5,253
Weight management	2,333		2,569
	62,523		56,314
North America:
General health	$	59,847	$	62,519
Immunity	15,341		16,202
Cardiovascular	18,750		19,518
Digestive	33,077		33,925
Personal care	6,170		5,751
Weight management	4,978		6,349
	138,163		144,264
Latin America and Other:
General health	$	6,919	$	7,584
Immunity	2,453		2,565
Cardiovascular	1,446		1,427
Digestive	10,258		11,360
Personal care	1,056		1,214
Weight management	861		1,051
	22,993		25,201
Total net sales	$	362,215	$	364,810

Schedule of consolidated property, plant and equipment by geographical locations

From an individual country perspective, only the United States comprise 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):

As of December 31	2019		2018
Property, plant and equipment
United States	$	54,470	$	60,606
Other	5,042		3,455
Total property, plant and equipment	$	59,512	$	64,061